Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Contract Win and Trading Update

30 Nov 2020 07:00

RNS Number : 8380G
Location Sciences Group PLC
30 November 2020
 

30 November 2020

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

New Contract Win, Trading Update and Change of Registered Office

 

Location Sciences (AIM: LSAI), the leading location verification company, is pleased to announce it has signed its second customer, The Spoken Thought, Inc., to its GeoProtect (Verify Audience) platform.

 

The Spoken Thought, Inc. (trading as Mira) is a high value audience segment supplier to leading brands and media agencies across the US. It will use the Location Sciences GeoProtect platform to independently verify audience segments in order to offer its customers a visibly differentiated premium product compared to its competitors.

 

The quality of the data used to build audience segments matters to brands and agencies and can dramatically impact the performance of their advertising campaigns. In today's data marketplace, however, it is virtually impossible for brands and agencies to distinguish between good and bad quality audience data. Consequently, Location Sciences' third-party independent certification is an excellent tool for suppliers of audience segments to clearly and visibly demonstrate the quality of their products in this crowded data marketplace.

 

Location Sciences and Mira have been developing their partnership throughout 2020 and the signing of this agreement crystalises an enormous amount of hard work by both parties. The partnership being entered into now should enable Mira to deliver more accurate high value audience segments to its customers.

 

Whilst revenues under this agreement are expected to begin to accrue to Location Sciences during the remainder of 2020, the main revenue benefit should become evident in 2021 and beyond.

Mark Slade, CEO, Location Sciences, commented: "Mira's decision to join a growing set of US suppliers in offering complete transparency to their customers is a testament to their business and commitment to high-quality products. This win builds on excellent work already underway with other suppliers, who are leveraging our partnership to win new business."

 

Jon Frangakis, CEO, Mira, added: "Working with Location Sciences gives us the platform to show our customers the true quality and accuracy of our audiences. We have been impressed with the GeoProtect platform and the Location Sciences team, and we look forward to progressing our partnership in 2021."

 

Trading Update

 

Throughout 2020, Verify revenues have been adversely impacted by significantly reduced advertising spend as a result of Covid-19, and the UK's second nationwide lockdown in November could not have come at a worse time for the business. Consequently, the anticipated pick up in Verify revenues in Q4 2020 (typically the busiest quarter for location-based advertising) has not materialised and therefore Verify revenues will be lower than the Company's expectations.

 

The directors remain confident in the market opportunity for Verify and expect revenues to increase from existing customers as well as new client wins as location-based advertising returns during the first half of 2021.

 

The reduced revenue from Verify has been partly offset with additional revenues secured from Location Science's Insights products, with new client wins for the Company's market leading geo-mobility insights, including securing a partnership with the NHS to help its efforts in fighting the transmission of Covid-19.

 

Supporting the NHS

 

Location Sciences data insights products continue to help to inform the ongoing response to Covid-19. Through its long-term partnership with CACI, Location Sciences is supplying data to support NHS England and members of the Scientific Pandemic Influenza Group on Modelling (SPI-M) in their analysis of how movement of individuals is impacting the reproduction number (R) and growth rate of Covid-19 in the UK.

 

Location Sciences is pleased to be supporting NHS England - helping it to understand how people are moving around and exploring how this may impact the spread of the Covid-19 virus.

 

Cash Resources Sufficient until 2022

 

As part of its ongoing efforts to mitigate the impact of Covid-19, the board has and is taking further measures to reduce the Company's overheads and seek operational efficiencies where possible. These actions include moving to remote working in London and the US and rationalising the Company's new business generation operations in the US. These actions will lead to the Company having reduced cash requirements such that the board now believes the Company has sufficient cash reserves until early 2022. As at 30 November 2020, the Company had cash of approximately £1.2 million.

 

Mark Slade, CEO, Location Sciences, comments: "The new partnerships developed in 2020 - in challenging circumstances - are incredibly encouraging. It's pleasing to see high-quality location data being valued by the advertising industry and beyond, as public sector bodies realise the impact of movement on society. As we move towards a new year, we are optimistic that we will continue this momentum."

 

Change of Registered Office

 

With effect from 1 December 2020, the Company's registered office will be moved to the Company's company secretarial offices at First Floor, St James House, St James Square, Cheltenham, Gloucestershire GL50 3PR.

 

A further update on trading and prospects is expected to be provided in late January 2021.

 

 

For further information please contact:

 

Location Sciences Group PLC

via Milk & Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, CFO and Commercial Director

 

 

 

Allenby Capital Limited (Nominated Adviser)

Tel: +44 (0)20 3328 5656

David Hart

James Hornigold

 

 

 

Peterhouse Capital (Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

 

About Location Sciences Group PLC:

 

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns.

 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

Rule 26 website: www.locationsciencesgroup.ai

Verify website: www.locationsciences.ai

LinkedIn: https://www.linkedin.com/company/locationsciences

Twitter: @LocationSci

 

About Mira

 

Mira (also known as The Spoken Thought) are a high value audience segment supplier to leading brands and media agencies across the US. In addition, Mira designs, builds, and operates data sets that make Out of Home media function more like digital media via its crowd analytics platform. Mira was founded in 2015 by two brothers, Jonathan and Gabe Frangakis and is based in New York, NY and Durham, NC.

 

Website: https://mira.co/

LinkedIn: https://www.linkedin.com/company/the-spoken-thought/

Twitter: @Mira_Analytics

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKCBNOBDDODB
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.